John Diodato is an experienced oncology and pathology collaborator currently serving as an Oncology Diagnostic Liaison at Pfizer since 2024. Previously, Diodato held various roles in the medical field, including positions at Caris Life Sciences, Tri-State Biologics, and Ambry Genetics, where they focused on education, account management, and sales in oncology. Diodato has a Bachelor of Science in Genetics from Rutgers University, obtained in 2012. Their extensive career includes significant contributions to biomarker testing protocols and collaboration within large health systems and academic centers across the Northeast US.
This person is not in the org chart
This person is not in any teams
This person is not in any offices